Project Grant R16AI186624
Award Date 9/12/25
Completion Date 8/31/29
Dollars Obligated $200K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
New York, USA
Similar Awards
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $238,972 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The Research Foundation for the State University of New York, doing business as Sponsored Projects Services, to study the role of the cellular protein EHD4 in restricting HIV-1 infection. The research aims to determine the mechanism by which EHD4 decreases the infectivity of HIV-1 particles by impacting the incorporation of...
- This $150,607 National Science Foundation project grant will support a research community development project focused on collaborative research related to knowledge of HIV/AIDS. Led by the University of Washington with a completion date of August 2026, the project aims to bring together social scientific and humanistic scholars within the interdisciplinary field of science and technology studies. Key activities over the three-year period will include organizing three annual workshops around...
- The National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research federal grant program (CFDA 93.855), awarded a $156,500 Project Grant to the University of Hawaii at Manoa. The funding will support research to establish human 2D and 3D testicular models to elucidate Monkeypox virus (MPXV) tropism and pathogenic mechanisms in the testes. This research aims to provide direct evidence of MPXV infection in human testis, including identifying...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $368,750 Project Grant to the Veterans Medical Research Foundation of San Diego through the Allergy and Infectious Diseases Research federal grant program (CFDA 93.855). The project aims to determine the mechanisms by which the short isoform of the BST2 protein, which has broad antiviral activity, is antagonized by HIV-1 and HIV-2. This research seeks to understand how HIV evades this key cellular defense and the...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $238,787 Project Grant under the Allergy and Infectious Diseases Research federal grant program (CFDA 93.855) to The Research Foundation for the State University of New York (RFSUNY), doing business as Stony Brook University. The grant, effective from February 1, 2025 to January 31, 2027, aims to track the secretion of ESX-1 substrates through the cell envelope of mycobacteria, including human pathogens like...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $859,992 Project Grant to Yale University for the "Molecular Investigations of HIV-1 Maturation Pathways and Inhibitor Actions in situ" research project. The grant, funded under NIAID's Allergy and Infectious Diseases Research Program (CFDA 93.855), aims to use advanced in-situ cryo-electron microscopy and tomography techniques to visualize the structural transitions of the HIV-1 virus during the maturation...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $822,015 Project Grant titled "NOVEL STATISTICAL METHODS FOR CONFOUNDED AND INCOMPLETE NETWORK DATA" to the University of Pennsylvania. This grant, provided under the NIAID's Allergy and Infectious Diseases Research program (CFDA 93.855), will fund the development of new statistical methodologies to address challenges posed by missing data, confounding, and complex social network structures in studies of public...
- This Project Grant award of $285,816 from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) will support research to enhance understanding of ADP-ribosylation (ADPR) and its role in HIV-1 latency and reactivation. The awardee, The Regents of the University of California, San Francisco, will conduct biochemical, proteomic, and cellular assays to identify global proteomic changes to ADPR during HIV-1 latency and reactivation,...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $1,379,954 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the Scripps Research Institute. The grant, awarded on August 21, 2025, supports research to engineer durable immunity by optimizing HIV vaccine parameters to drive long-lived plasma cell development. The project aims to systematically study the effects of immunogen affinity, valency, adjuvants, vaccine platforms, and...
- This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research Federal Grant Program (CFDA 93.855), provides $479,925 to support research on the mechanisms by which HIV-1 infection induces the production of type I interferons (IFNs) in human immune cells. The project aims to investigate whether cell-to-cell transmission of HIV-1, rather than cell-free viral infection, is a key driver of IFN activation through...